Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-FR
Language English French
Date Updated 2021-02-02 2020-09-18
Drug Identification Number 02197502 02197502
Brand name SELECT 1/35 (21-DAY) SELECT 1/35 (21-DAY)
Common or Proper name SELECT 21 SELECT 21
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients NORETHINDRONE ETHINYL ESTRADIOL NORETHINDRONE ETHINYL ESTRADIOL
Strength(s) 1.0MG 0.035MG 1.0MG 0.035MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 21's 21's
ATC code G03AA G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-18 2020-09-18
Estimated end date 2021-02-01 Unknown
Actual end date 2021-02-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Recovery expected during Feb 2021. Limited amount of product expected to be available in Q1 2021. Recovery expected in Q2 2021.
Health Canada comments